Panoskaltsis-Mortari A - Search Results

1

Intracranial therapy of glioblastoma with the fusion protein DTIL13 in immunodeficient mice.

Rustamzadeh E, Hall WA, Todhunter DA, Low WC, Liu H, Panoskaltsis-Mortari A, Vallera DA. Rustamzadeh E, et al. Int J Cancer. 2006 May 15;118(10):2594-601. doi: 10.1002/ijc.21647. Int J Cancer. 2006. PMID: 16358262

2

Therapy for ongoing graft-versus-host disease induced across the major or minor histocompatibility barrier in mice with anti-CD3F(ab')2-ricin toxin A chain immunotoxin.

Vallera DA, Taylor PA, Panoskaltsis-Mortari A, Blazar BR. Vallera DA, et al. Blood. 1995 Dec 1;86(11):4367-75. Blood. 1995. PMID: 7492798 Free article.

3

Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts.

Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Gray GS, Vallera DA. Blazar BR, et al. Blood. 1995 May 1;85(9):2607-18. Blood. 1995. PMID: 7537122 Free article.

4

Interleukin-1 or tumor necrosis factor-alpha antagonists do not inhibit graft-versus-host disease induced across the major histocompatibility barrier in mice.

Vallera DA, Taylor PA, Vannice JL, Panoskaltsis-Mortari A, Blazar BR. Vallera DA, et al. Transplantation. 1995 Dec 15;60(11):1371-4. Transplantation. 1995. PMID: 8525541

5

Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens.

Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Barrett TA, Bluestone JA, Vallera DA. Blazar BR, et al. Blood. 1996 Jan 15;87(2):827-37. Blood. 1996. PMID: 8555509 Free article.

6

Lack of GVHD across classical, single minor histocompatibiliTy (miH) locus barriers in mice.

Blazar BR, Roopenian DC, Taylor PA, Christianson GJ, Panoskaltsis-Mortari A, Vallera DA. Blazar BR, et al. Transplantation. 1996 Feb 27;61(4):619-24. doi: 10.1097/00007890-199602270-00017. Transplantation. 1996. PMID: 8610390

7

In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A.

Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Sehgal S, Vallera DA. Blazar BR, et al. Blood. 1996 May 1;87(9):4001-9. Blood. 1996. PMID: 8611733 Free article.

8

Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single-chain Fv fusion immunotoxin specifically targeting the CD3 epsilon moiety of the T-cell receptor.

Vallera DA, Panoskaltsis-Mortari A, Jost C, Ramakrishnan S, Eide CR, Kreitman RJ, Nicholls PJ, Pennell C, Blazar BR. Vallera DA, et al. Blood. 1996 Sep 15;88(6):2342-53. Blood. 1996. PMID: 8822957 Free article.

9

Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.

Blazar BR, Sharpe AH, Taylor PA, Panoskaltsis-Mortari A, Gray GS, Korngold R, Vallera DA. Blazar BR, et al. J Immunol. 1996 Oct 15;157(8):3250-9. J Immunol. 1996. PMID: 8871619

10

Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.

Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Buhlman J, Xu J, Flavell RA, Korngold R, Noelle R, Vallera DA. Blazar BR, et al. J Immunol. 1997 Jan 1;158(1):29-39. J Immunol. 1997. PMID: 8977172

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters